ACACIA PHARMA, INC.

BARHEMSYS

Manufacturer:

ACACIA PHARMA, INC.

Barhemsys HCPCS:

J0184

HCPCS Code Descriptor:

Injection, amisulpride, 1 mg

Category:

J Code

Barhemsys NDCs:

71390-0125-50, 71390-0125-20

Primary Type:

Anti-Emetic

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Barhemsys:

BARHEMSYS is an Anti-Emetic drug manufactured by ACACIA PHARMA, INC. and administered via the Intravenous route of administration. The J Code: J0184 is aligned to the drug BARHEMSYS.

Barhemsys is an injection used to treat or prevent nausea and vomiting after patients have undergone surgery. Barhemsys is given to patients via intravenous infusion to help relieve and prevent the sickness and discomfort that is common after having undergone surgery. It can be used alone, or in combination with other medications.

ACCESS PRICING AND MORE BY REGISTERING

J0184 Added Date:

January 1, 2024

J0184 Effective Date:

January 1, 2024

J0184 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Barhemsys billing and coding information.
Our team did not identify a source for Barhemsys patient assistance information. Please reach out to our team if you feel that this is a mistake.
BARHEMSYS prescribing information can be found at the link below:
Information regarding BARHEMSYS’s side effects can be found at MedlinePlus